Potassium Cl 2meq/ml Inj 250ml

Manufacturer B. BRAUN MEDICAL Active Ingredient Potassium Chloride Injection Solution(poe TASS ee um KLOR ide) Pronunciation poe TASS ee um KLOR ide
It is used to treat or prevent low potassium levels.
đŸˇī¸
Drug Class
Electrolyte replacement
đŸ§Ŧ
Pharmacologic Class
Mineral; Electrolyte
🤰
Pregnancy Category
Category C
✅
FDA Approved
Jan 1970
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Potassium chloride is a medicine given through a vein (IV) to replace potassium in your body. Potassium is a very important mineral that helps your heart, nerves, and muscles work correctly. It's used when your body doesn't have enough potassium, which can happen due to certain illnesses, medications, or not getting enough in your diet.
📋

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and carefully read all accompanying information. Take this medication exactly as directed, and adhere to all instructions provided. This drug is administered as an intravenous infusion, which means it is given into a vein over a specified period of time.

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.

If you miss a dose, contact your doctor immediately to receive guidance on the appropriate course of action.
💡

Lifestyle & Tips

  • For patients receiving IV potassium, dietary changes are usually not the primary treatment. However, once stable, your doctor may recommend increasing potassium-rich foods (e.g., bananas, oranges, potatoes, leafy greens) to help maintain levels.
  • Avoid excessive alcohol intake, which can contribute to electrolyte imbalances.
  • Report any new medications or supplements to your healthcare provider, especially those that can affect potassium levels (e.g., certain blood pressure medications, diuretics).

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Highly individualized based on serum potassium levels, clinical condition, and ongoing losses. Typically administered intravenously at a rate not exceeding 10-20 mEq/hour. Maximum concentration for peripheral infusion is usually 40 mEq/L; for central line, up to 60-80 mEq/L. NEVER administer undiluted or as an IV push.
Dose Range: 10 - 40 mg

Condition-Specific Dosing:

mildHypokalemia: 20-40 mEq IV over 2-4 hours, or oral replacement.
moderateHypokalemia: 40-80 mEq IV over 4-8 hours, or oral replacement.
severeHypokalemia: 40-100 mEq IV over 2-10 hours, with continuous ECG monitoring. Max rate 20 mEq/hr (or higher in life-threatening situations with extreme caution and continuous monitoring).
diabeticKetoacidosis: Often requires significant potassium replacement as insulin drives potassium intracellularly.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established for routine use; highly specialized. Dosing typically 0.5-1 mEq/kg/day for maintenance, or 0.25-0.5 mEq/kg/dose for repletion, infused slowly.
Infant: 0.5-1 mEq/kg/day for maintenance, or 0.25-0.5 mEq/kg/dose for repletion, infused slowly. Max rate 0.5 mEq/kg/hr.
Child: 0.5-1 mEq/kg/day for maintenance, or 0.25-0.5 mEq/kg/dose for repletion, infused slowly. Max rate 0.5 mEq/kg/hr (or 1 mEq/kg/hr in severe cases with continuous monitoring). Max concentration 40 mEq/L.
Adolescent: Similar to adult dosing, but adjusted for weight and clinical status. Max rate 10-20 mEq/hr.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: Use with caution; monitor serum potassium closely.
Moderate: Significant dose reduction required; monitor serum potassium and renal function frequently. Avoid if possible.
Severe: Contraindicated in anuric or oliguric patients unless on dialysis. If dialysis is initiated, dose carefully based on serum levels and dialysis schedule.
Dialysis: Generally avoided in patients with end-stage renal disease unless serum potassium is low and patient is on dialysis. Dosing must be highly individualized and guided by frequent serum potassium measurements.

Hepatic Impairment:

Mild: No specific adjustment needed, but monitor for fluid and electrolyte imbalances.
Moderate: No specific adjustment needed, but monitor for fluid and electrolyte imbalances.
Severe: No specific adjustment needed, but monitor for fluid and electrolyte imbalances, especially if ascites or renal impairment is present.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Potassium is the major intracellular cation and is essential for the maintenance of acid-base balance, isotonicity, and cell electrodynamic function. It is involved in nerve impulse transmission, muscle contraction (especially cardiac muscle), and carbohydrate metabolism. Potassium chloride provides potassium ions to correct hypokalemia and chloride ions to correct associated hypochloremia.
📊

Pharmacokinetics

Absorption:

Bioavailability: 100% (intravenous)
Tmax: Rapid (within minutes of IV administration)
FoodEffect: Not applicable for IV administration

Distribution:

Vd: Approximately 0.5 L/kg (reflects total body water, primarily intracellular)
ProteinBinding: Not protein bound
CnssPenetration: Limited (maintains concentration gradient)

Elimination:

HalfLife: Not applicable (homeostatically regulated); plasma half-life is very short as it rapidly equilibrates into cells.
Clearance: Primarily renal excretion, influenced by aldosterone, acid-base status, and tubular flow.
ExcretionRoute: Renal (glomerular filtration and tubular secretion)
Unchanged: Nearly 100%
âąī¸

Pharmacodynamics

OnsetOfAction: Immediate (IV)
PeakEffect: Within minutes to hours, depending on infusion rate and deficit
DurationOfAction: Depends on renal function, ongoing losses, and homeostatic mechanisms; typically hours to days for sustained effect.

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high potassium levels, including:
+ Abnormal heartbeat
+ Confusion
+ Weakness
+ Lightheadedness or dizziness
+ Feeling like passing out
+ Numbness or tingling
+ Shortness of breath
Slow heartbeat
Chest pain or pressure
Signs of low sodium levels, such as:
+ Headache
+ Difficulty focusing
+ Memory problems
+ Confusion
+ Weakness
+ Seizures
+ Changes in balance
Shortness of breath, significant weight gain, or swelling in the arms or legs
* Tissue damage at the injection site, characterized by:
+ Redness
+ Burning
+ Pain
+ Swelling
+ Blisters
+ Skin sores
+ Leaking of fluid

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people experience no side effects or only mild ones. If you have any side effects that bother you or persist, contact your doctor for guidance.

Reporting Side Effects

If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Symptoms of too much potassium (hyperkalemia): unusual tiredness, weakness, numbness or tingling, slow or irregular heartbeat, nausea, vomiting, diarrhea, abdominal pain.
  • Symptoms of too little potassium (hypokalemia) returning: muscle weakness, cramps, fatigue, constipation, irregular heartbeat.
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction and its symptoms.
If you have high potassium levels, as this may affect the safety of taking this medication.
If you are currently taking any of the following medications: Amiloride, Eplerenone, Spironolactone, or Triamterene, as these may interact with this drug.

Please note that this is not an exhaustive list of all potential interactions. To ensure your safety, it is crucial to:

Inform your doctor and pharmacist about all the medications you are taking, including prescription and over-the-counter drugs, natural products, and vitamins.
Discuss all your health problems with your doctor to determine if it is safe for you to take this medication.
Never start, stop, or change the dose of any medication without first consulting your doctor to avoid potential interactions or adverse effects.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood tests will be necessary, as directed by your doctor, to monitor your condition. Be sure to discuss any concerns or questions with your doctor.

To minimize the risk of severe side effects, it is crucial to adhere to the prescribed dosage and not exceed the amount recommended by your doctor. If you follow a low-salt diet or use a salt substitute, consult with your doctor to discuss any potential interactions.

Certain formulations of this medication may not be suitable for children, so it is essential to consult with your doctor if you have any questions or concerns. Additionally, if you are pregnant, planning to become pregnant, or breastfeeding, you should discuss the potential benefits and risks of this medication with your doctor to make an informed decision about your treatment.
🆘

Overdose Information

Overdose Symptoms:

  • Hyperkalemia (serum K+ > 5.0 mEq/L)
  • Cardiac arrhythmias (peaked T waves, widened QRS, ventricular fibrillation, asystole)
  • Muscle weakness, flaccid paralysis
  • Paresthesias
  • Confusion
  • Hypotension

What to Do:

Immediate discontinuation of potassium infusion. Administration of calcium gluconate (to stabilize cardiac membrane), insulin and glucose (to shift potassium intracellularly), sodium bicarbonate (for acidosis), loop diuretics (if renal function adequate), or emergent hemodialysis for severe, refractory hyperkalemia. Continuous ECG monitoring is essential. Call 1-800-222-1222 (Poison Control).

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene) in patients with hyperkalemia or significant renal impairment
  • Patients with hyperkalemia (serum potassium > 5.0 mEq/L)
  • Severe renal impairment (anuria, oliguria) unless on dialysis
  • Addison's disease (untreated)
  • Acute dehydration
  • Extensive tissue breakdown (e.g., severe burns, rhabdomyolysis) where hyperkalemia is a risk
🔴

Major Interactions

  • ACE inhibitors (e.g., lisinopril, enalapril): Increased risk of hyperkalemia
  • Angiotensin Receptor Blockers (ARBs) (e.g., valsartan, losartan): Increased risk of hyperkalemia
  • NSAIDs (e.g., ibuprofen, naproxen): May impair renal potassium excretion, increasing hyperkalemia risk
  • Cyclosporine, Tacrolimus: May increase serum potassium levels
  • Heparin: Can cause hypoaldosteronism, leading to hyperkalemia
  • Beta-blockers (non-selective): May impair cellular potassium uptake, increasing serum potassium
🟡

Moderate Interactions

  • Digoxin: Hypokalemia potentiates digoxin toxicity; hyperkalemia can reduce digoxin efficacy.
  • Insulin: Drives potassium into cells, potentially causing transient hypokalemia (relevant during DKA treatment).
  • Corticosteroids: May increase renal potassium excretion, potentially requiring higher potassium doses.
đŸŸĸ

Minor Interactions

  • Laxatives (chronic use): May increase potassium loss from GI tract.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Serum Potassium (K+)

Rationale: To determine the degree of hypokalemia and guide initial dosing.

Timing: Prior to initiation of therapy.

Renal Function (BUN, Serum Creatinine)

Rationale: Potassium is primarily renally excreted; impaired renal function increases risk of hyperkalemia.

Timing: Prior to initiation of therapy.

Electrocardiogram (ECG)

Rationale: To assess for cardiac manifestations of hypokalemia (e.g., U waves, flattened T waves, ST depression) and establish baseline cardiac rhythm.

Timing: Prior to initiation, especially in severe hypokalemia.

Other Electrolytes (Magnesium, Calcium, Phosphate)

Rationale: Hypomagnesemia can impair potassium repletion; other electrolyte imbalances may coexist.

Timing: Prior to initiation.

📊

Routine Monitoring

Serum Potassium (K+)

Frequency: Every 2-4 hours during active repletion for severe hypokalemia; every 6-12 hours for moderate; daily for maintenance.

Target: 3.5-5.0 mEq/L

Action Threshold: If K+ > 5.0 mEq/L, stop infusion and assess for hyperkalemia. If K+ < 3.0 mEq/L, consider increasing infusion rate (within safe limits) or adding oral supplementation.

Electrocardiogram (ECG)

Frequency: Continuous monitoring during rapid infusion or severe hypokalemia; intermittent monitoring otherwise.

Target: Normal sinus rhythm, absence of hyperkalemia/hypokalemia changes.

Action Threshold: Development of peaked T waves, widened QRS, PR prolongation (hyperkalemia) or U waves, flattened T waves, ST depression (hypokalemia) requires immediate intervention.

Renal Function (BUN, Serum Creatinine)

Frequency: Daily or as clinically indicated, especially in patients with pre-existing renal impairment.

Target: Stable or improving

Action Threshold: Significant worsening of renal function requires re-evaluation of potassium dosing.

Fluid Balance (Intake/Output)

Frequency: Every 4-8 hours

Target: Appropriate for patient's condition

Action Threshold: Significant fluid overload or dehydration requires adjustment of IV fluids.

Vital Signs (Heart Rate, Blood Pressure)

Frequency: Every 1-4 hours during infusion

Target: Within normal limits for patient

Action Threshold: Significant changes may indicate cardiac effects of potassium imbalance.

đŸ‘ī¸

Symptom Monitoring

  • Muscle weakness
  • Fatigue
  • Muscle cramps
  • Paresthesias (tingling, numbness)
  • Palpitations or irregular heartbeat
  • Nausea, vomiting, abdominal distension
  • Decreased bowel sounds (ileus)
  • Confusion or altered mental status

Special Patient Groups

🤰

Pregnancy

Potassium is an essential electrolyte. Replacement therapy is indicated when hypokalemia occurs during pregnancy. Use with caution and monitor serum levels closely. Category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Trimester-Specific Risks:

First Trimester: No specific increased risk identified beyond general electrolyte balance.
Second Trimester: No specific increased risk identified beyond general electrolyte balance.
Third Trimester: No specific increased risk identified beyond general electrolyte balance. Monitor for fluid overload, especially in preeclampsia.
🤱

Lactation

Potassium is a normal component of breast milk. Excretion into breast milk is expected but unlikely to cause adverse effects in a healthy, full-term infant when administered to the mother in therapeutic doses. Monitor infant for signs of electrolyte imbalance if mother receives high doses.

Infant Risk: Low risk at therapeutic doses.
đŸ‘ļ

Pediatric Use

Dosing must be carefully calculated based on weight, age, and severity of hypokalemia. Infusion rates and concentrations must be strictly adhered to, as children are more susceptible to the adverse effects of hyperkalemia. Continuous ECG monitoring is often recommended for moderate to severe hypokalemia.

👴

Geriatric Use

Elderly patients are at increased risk for renal impairment, which can lead to decreased potassium excretion and an increased risk of hyperkalemia. They may also be on medications that affect potassium levels (e.g., ACE inhibitors, diuretics). Close monitoring of renal function and serum potassium is essential. Start with lower doses and titrate carefully.

Clinical Information

💎

Clinical Pearls

  • NEVER administer concentrated potassium chloride (e.g., 2 mEq/mL) undiluted or as an IV push. This is a lethal dose and can cause immediate cardiac arrest.
  • Always dilute potassium chloride concentrate in a large volume of IV fluid (e.g., D5W, NS) before administration.
  • Maximum recommended peripheral infusion concentration is typically 40 mEq/L. Higher concentrations (up to 60-80 mEq/L) may be used via central venous access with continuous cardiac monitoring.
  • Maximum infusion rate should generally not exceed 10-20 mEq/hour in adults, except in life-threatening situations with continuous ECG monitoring and close supervision.
  • Rapid infusion can cause local pain and phlebitis at the injection site. Use a large vein and ensure proper dilution.
  • Always correct hypomagnesemia before or concurrently with potassium repletion, as magnesium is required for cellular potassium uptake.
  • Monitor serum potassium, renal function, and ECG frequently during potassium replacement therapy.
  • Patients with renal impairment are at significantly higher risk of hyperkalemia; dose adjustments are crucial.
  • Be aware of drug interactions that can increase serum potassium (e.g., ACE inhibitors, ARBs, potassium-sparing diuretics, NSAIDs).
🔄

Alternative Therapies

  • Oral potassium supplements (e.g., potassium chloride tablets, liquid solutions) for mild to moderate hypokalemia or maintenance.
  • Dietary modifications (increasing intake of potassium-rich foods like fruits, vegetables, and certain dairy products) for mild hypokalemia or prevention.
💰

Cost & Coverage

Average Cost: Relatively inexpensive per vial/bag
Generic Available: Yes
Insurance Coverage: Tier 1 (Generic)
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor for further guidance. To ensure safe use, never share your medication with others, and do not take medication prescribed for someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless instructed to do so by a healthcare professional, do not flush medications down the toilet or pour them down the drain. If you are unsure about the proper disposal method, consult your pharmacist, who can also inform you about potential drug take-back programs in your area. Some medications may come with an additional patient information leaflet, which your pharmacist can provide. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek medical attention. Be prepared to provide information about the medication taken, the amount, and the time it was taken to ensure prompt and effective treatment.